Age Differences in Breast Cancer Pathways
Author Information
Author(s): Anders Carey K., Acharya Chaitanya R., Hsu David S., Broadwater Gloria, Garman Katherine, Foekens John A., Zhang Yi, Wang Yixin, Marcom Kelly, Marks Jeffrey R., Mukherjee Sayan, Nevins Joseph R., Blackwell Kimberly L., Potti Anil
Primary Institution: Duke University
Hypothesis
To define the biology driving the aggressive nature of breast cancer arising in young women.
Conclusion
Breast cancer in young women shows distinct biological characteristics that could inform targeted treatment strategies.
Supporting Evidence
- Young women with breast cancer have a higher probability of PI3K and Myc pathway deregulation.
- Distinct patterns of oncogenic pathway deregulation were identified in young women compared to older women.
- The study found that younger age at diagnosis is a significant predictor of poorer outcomes.
Takeaway
Young women with breast cancer have different tumor characteristics than older women, which can help doctors choose better treatments.
Methodology
The study analyzed gene expression data from 784 breast cancer patients, focusing on age-specific cohorts and oncogenic pathway deregulation.
Limitations
The study did not include patients aged 45-65 years, which may limit the generalizability of the findings.
Participant Demographics
Patients were divided into two age groups: young (≤45 years) and older (≥65 years).
Statistical Information
P-Value
p=0.006 for PI3K, p=0.03 for Myc
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website